These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15607829)

  • 21. In vivo characterization of 6beta-naltrexol, an opioid ligand with less inverse agonist activity compared with naltrexone and naloxone in opioid-dependent mice.
    Raehal KM; Lowery JJ; Bhamidipati CM; Paolino RM; Blair JR; Wang D; Sadée W; Bilsky EJ
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1150-62. PubMed ID: 15716384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence.
    Walker EA; Sterious SN
    Br J Pharmacol; 2005 Aug; 145(7):975-83. PubMed ID: 15912139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of kappa and delta opioid receptors in mediating morphine-induced antinociception in morphine-tolerant infant rats.
    Stoller DC; Sim-Selley LJ; Smith FL
    Brain Res; 2007 Apr; 1142():28-36. PubMed ID: 17300766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of morphine dependence and withdrawal by glycine B site antagonists in rats.
    Kotlińska J
    Pharmacol Biochem Behav; 2001 Jan; 68(1):157-61. PubMed ID: 11274720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of naltrindole on morphine-induced tolerance and physical dependence in rats.
    Hepburn MJ; Little PJ; Gingras J; Kuhn CM
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1350-6. PubMed ID: 9190871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effects of morphine-6-glucuronide, an active metabolite of morphine, and morphine on locomotor activity in mice: involvement of the opioid receptor.
    Uchihashi Y; Kuribara H; Morita T; Kitani Y; Karasawa F; Sato T
    Pharmacol Toxicol; 1996 May; 78(5):322-6. PubMed ID: 8737968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pharmacological modulation of opiate withdrawal using an up-/down-regulation of the noradrenergic system in opiate-dependent rats.
    Streel E; Dan B; Campanella S; Meyvaert A; Hanak C; Pelc I; Verbanck P
    Int J Neuropsychopharmacol; 2006 Oct; 9(5):621-6. PubMed ID: 16146582
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of spinal mu opioid receptors in the development of morphine tolerance and dependence.
    DeLander GE; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1984 Oct; 231(1):91-6. PubMed ID: 6092607
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultra-low dose naloxone restores the antinociceptive effect of morphine in pertussis toxin-treated rats by reversing the coupling of mu-opioid receptors from Gs-protein to coupling to Gi-protein.
    Tsai RY; Tai YH; Tzeng JI; Cherng CH; Yeh CC; Wong CS
    Neuroscience; 2009 Dec; 164(2):435-43. PubMed ID: 19682558
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.
    Dunbar SA; Karamian I; Zhang J
    Eur J Pain; 2007 Jan; 11(1):1-6. PubMed ID: 16448827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of naltrindole on the development of physical dependence on morphine in mice: a behavioral and biochemical study.
    Suzuki T; Tsuji M; Mori T; Misawa M; Nagase H
    Life Sci; 1995; 57(17):PL247-52. PubMed ID: 7564899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid system contribution to the antidepressant-like action of m-trifluoromethyl-diphenyl diselenide in mice: A compound devoid of tolerance and withdrawal syndrome.
    Rosa SG; Pesarico AP; Tagliapietra CF; da Luz SC; Nogueira CW
    J Psychopharmacol; 2017 Sep; 31(9):1250-1262. PubMed ID: 28857657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
    Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relative involvement of spinal opioid receptors in physical dependence on intrathecal butorphanol and morphine.
    Wongchanapai W; Tsang BK; He Z; Ho IK
    Pharmacol Biochem Behav; 1998 Aug; 60(4):899-907. PubMed ID: 9700974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms.
    Pałucha A; Brański P; Pilc A
    Pol J Pharmacol; 2004; 56(6):863-6. PubMed ID: 15662102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.